• 1
    Dozois RR, Kelly KA. The surgical management of ulcerative colitis. In: KirsnerJB, ed. Inflammatory Bowel Disease, 5th edn. Philadelphia: W.B. Saunders, 2000: 62657.
  • 2
    Sandborn WJ. Pouchitis in the Kock continent ileostomy and the ileoanal pouch. In: KirsnerJB, ed. Inflammatory Bowel Disease, 5th edn. Philadelphia: W.B. Saunders, 2000: 73647.
  • 3
    Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis and treatment. Gastroenterology 1994; 107: 185660.
  • 4
    Patel RT, Bain I, Youngs D, Keighley MRB. Cytokine production in pouchitis is similar to that in ulcerative colitis. Dis Colon Rectum 1995; 38: 831.
  • 5
    Bulois P, Tremaine WJ, Maunoury V, et al. Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10. Inflamm Bowel Dis 2000; 6: 15764.
  • 6
    Evgenikos N, Bartolo DCC, Hamer-Hodges DW, Gosh S. Assessment of ileoanal pouch inflammation by interleukin 1β and interleukin 8 concentrations in the gut lumen. Dis Colon Rectum 2002; 45: 24955.
  • 7
    Patel RT, Pall AA, Adu D, Keighley MR. Circulating adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 103741.
  • 8
    Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH , Phillips S. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994; 69: 40915.
  • 9
    Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 2617.
  • 10
    Sandborn WJ. Pouchitis: definition, risk factors, frequency, natural history, classification, and public health perspective. In: McLeodRS, MartinF, SutherlandLR, et al., eds. Trends in Inflammatory Bowel Disease 1996. Lancaster: Kluwer Academic Publishers, 1997: 5163.
  • 11
    Mimura T, Rizzello F, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 90917.
  • 12
    Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 3059.
  • 13
    Goldstein NS, Sanford WW, Bodzin JH. Crohn's-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis. Am J Surg Pathol 1998; 22: 10401.
  • 14
    Dayton MT, Larsen KR, Christiansen DD. Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis. Arch Surg 2002; 137: 6905.
  • 15
    MacLean AR, O'Connor B, Parkes R, Cohen Z, McLeod RS. Reconstructive surgery for failed ileal pouch-anal anastomosis: a viable surgical option with acceptable results. Dis Colon Rectum 2002; 45: 8806.
  • 16
    MacRae HM, McLeod RS, Cohen Z, O'Connor BI, Ton EN. Risk factors for pelvic failure. Dis Colon Rectum 1997; 40: 25762.
  • 17
    Gecim IE, Wolff BG, Pemberton JH, Devine RM, Dozois RR. Does technique of anastomosis play any role in developing late perianal abscess or fistula? Dis Colon Rectum 2000; 43: 12415.
  • 18
    Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Successful management of Crohn's disease of the ileoanal pouch with infliximab. Gastroenterology 1999; 117: 42932.
  • 19
    Sheperd NA, Hulten L, Tytgat GNI, et al. Workshop: Pouchitis. Int J Colorect Dis 1989; 4: 20529.
  • 20
    Warren BF, Shepherd NA. The role of pathology in pelvic ileal reservoir surgery. Int J Colorect Dis 1992; 7: 6875.
  • 21
    Jenkins D, Balsitis M, Gallivan S, et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol 1997; 50: 93105.
  • 22
    Arnott IDR, McDonald D, Williams A, Ghosh S. Clinical use of infliximab in Crohn's disease: the Edinburgh experience. Aliment Pharmacol Ther 2001; 15: 163946.
  • 23
    Martin A, Leone L, Fries W, Naccarato R. Quality of life in inflammatory bowel disease. Ital J Gastroenterol 1995; 27: 4504.
  • 24
    Subramani K, Harpaz N, Bilotta J, et al. Refractory pouchitis: does it reflect underlying Crohn's disease? Gut 1993; 34: 153942.
  • 25
    Facklis K, Plevy SE, Vasiliauskas EA, et al. Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications. Dis Colon Rectum 1999; 42: 6015.
  • 26
    Kuhbacher T, Gionchetti P, Hampe J, et al. Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis. Clin Exp Immunol 2001; 123: 395401.
  • 27
    Achkar JP, Lashner BA. TNF haplotype and pouch complications: invited editorial. Dis Colon Rectum 1999; 42: 6056.